Titel

Merkliste
1 Ergebnisse

Antigen-Drug Conjugates as a Novel Therapeutic Class for th..:

Pickens, Chad J ; Christopher, Matthew A ; Leon, Martin A...
Pickens, C. J., Christopher, M. A., Leon, M. A., Pressnall, M. M., Johnson, S. N., Thati, S., Sullivan, B. P., & Berkland, C. (2019). Antigen-Drug Conjugates as a Novel Therapeutic Class for the Treatment of Antigen-Specific Autoimmune Disorders. Molecular pharmaceutics, 16(6), 2452–2461. https://doi.org/10.1021/acs.molpharmaceut.9b00063. , 2019

Link: http://hdl.handle.net/1808/30978

RT Journal
T1 <Title>Antigen-Drug Conjugates as a Novel Therapeutic Class for the Treatment of Antigen-Specific Autoimmune Disorders</Title>

UL https://suche.suub.uni-bremen.de/peid=base-ftunivkansas:oai:kuscholarworks.ku.edu:1808_30978&Exemplar=1&LAN=DE
				
A1 Pickens, Chad J
A1 Christopher, Matthew A
A1 Leon, Martin A
A1 Pressnall, Melissa M
A1 Johnson, Stephanie N
A1 Thati, Sharadvi
A1 Sullivan, Bradley P
A1 Berkland, Cory
PB American Chemical Society
YR 2019
K1 Autoimmunity
K1 Antigen-specific immunotherapy
K1 Copper-catalyzed azide-alkyne cycloaddition
K1 Experimental autoimmune encephalomyelitis
K1 Antigen-drug conjugate
JF Pickens, C. J., Christopher, M. A., Leon, M. A., Pressnall, M. M., Johnson, S. N., Thati, S., Sullivan, B. P., & Berkland, C. (2019). Antigen-Drug Conjugates as a Novel Therapeutic Class for the Treatment of Antigen-Specific Autoimmune Disorders. Molecular pharmaceutics, 16(6), 2452–2461. https://doi.org/10.1021/acs.molpharmaceut.9b00063
LK http://hdl.handle.net/1808/30978
DO http://hdl.handle.net/1808/30978
SF ELIB - SuUB Bremen

Export

RefWorks (nur Desktop-Version!)
Flow (Zuerst in Flow einloggen, dann importieren)